Top Buy
| Security ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.88 | - | - |
| United Therapeutics | 27 | 1 | 5 | 1 | €328.10 | €341.51 | 4.087% |
| Ultragenyx Pharmaceutical Inc. | 25 | 1 | 4 | 0 | €51.00 | €84.74 | 66.165% |
| Tenet Healthcare | 42 | 0 | 4 | 0 | €149.00 | €154.91 | 3.968% |
| Taro Pharmaceutical Industries Ltd | 9 | 0 | 0 | 0 | €40.00 | - | - |
| Select Medical Holdings | 7 | 0 | 2 | 0 | €31.80 | €36.90 | 16.025% |
| Sartorius AG VZO | 3 | 0 | 0 | 0 | €247.30 | - | - |
| Repligen Corp. | 15 | 0 | 4 | 0 | €130.50 | €178.01 | 36.408% |
| QIAGEN NV | 12 | 0 | 1 | 0 | €40.47 | €47.52 | 17.415% |
| PTC Therapeutics Inc. | 15 | 9 | 3 | 0 | €31.60 | €41.51 | 31.369% |
| Perrigo Co. plc | 4 | 0 | 0 | 0 | €26.31 | €35.01 | 33.049% |
| Omnicell Inc. | 3 | 2 | 1 | 0 | €40.80 | €36.81 | -9.784% |
| Novocure Ltd | 1 | 1 | 0 | 0 | €17.84 | - | - |
| Neurocrine Bioscience | 46 | 0 | 11 | 0 | €114.70 | €149.74 | 30.546% |
| Nektar Therapeutics | 4 | 1 | 0 | 0 | €1.16 | €2.40 | 107.612% |
| Myriad Genetics | 4 | 3 | 0 | 1 | €25.40 | €22.15 | -12.806% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.40 | €65.00 | -3.561% |
| Molina Healthcare | 17 | 1 | 2 | 0 | €316.40 | €370.26 | 17.023% |
| Merit Medical Systems | 22 | 0 | 3 | 0 | €86.00 | €90.45 | 5.179% |
| Medpace Holdings Inc | 16 | 0 | 0 | 0 | €322.60 | €418.12 | 29.610% |
| Masimo Corp. | 7 | 1 | 1 | 0 | €105.05 | €151.02 | 43.764% |
| LivaNova plc | 12 | 0 | 1 | 0 | €42.00 | €66.49 | 58.314% |
| Jazz Pharmaceuticals plc | 30 | 0 | 6 | 0 | €105.00 | €183.41 | 74.680% |
| Iovance Biotherapeutics Inc. | 20 | 2 | 1 | 0 | €10.39 | €26.24 | 152.634% |
| Ionis Pharmaceuticals Inc. | 28 | 6 | 2 | 1 | €43.71 | €56.72 | 29.768% |